Publishing and
the Editorial process

Have you got a specific question you would like to ask our Editors?
We are currently collecting questions to open the discussion.
Feel free to fill in the form below!

Panelists
We are excited to share with you all the list of invited editors who will join our panel discussion on Sat, June 15th:

Keith Fox, Senior executive editor, Nucleic Acid Research
Keith Fox is Professor of Biochemistry in the School of Biological Sciences at the University of Southampton, UK. He studied Natural Sciences in Cambridge, where he also completed his PhD in the department of Pharmacology in 1980. He moved to Southampton in 1987 and was appointed to a personal chair on 2000. His main research interests concern the interaction of small molecules, proteins and oligonucleotides with DNA as well as the properties of unusual DNA structures (triplexes and quadruplexes); he has published over 200 papers in these areas. He has been an Executive Editor of Nucleic Acids Research since 2000 and a Senior Executive Editor of the journal since 2008. Some of his views on pre-print servers are expressed in a recent NAR Editorial [1].
[1] Stoddard, B.L. and Fox, K.R. (2019) Editorial: Preprints, citations and Nucleic Acids Research. Nucleic Acids Research 47, 1–2 https://doi.org/10.1093/nar/gky1229

Ines Alvarez-Garcia, Senior Editor, PLOS Biology
Ines Alvarez-Garcia graduated in Zoology at Universidad Complutense in Madrid and was awarded a PhD from the University of Cambridge in 2001. She moved to Boston and worked as a postdoc in the Biolabs at Harvard University until 2004. After a short collaboration at EMBL in Heidelberg, she moved back to Cambridge to do a second postdoc at the Zoology department. She joined the PLOS Biology team in April 2009.

Agnieszka Chacinska, Reviewing Editor, eLIFE
Agnieszka Chacinska graduated in Biology, University of Warsaw. In 2000 she received the doctoral degree in biochemistry at the Institute of Biochemistry and Biophysics of Polish Academy of Sciences. In the years 2001-2009 Agnieszka Chacińska worked at the University of Freiburg, as a postdoc and head of a research group. Since 2009 she has been based at the International Institute of Molecular and Cell Biology in Warsaw, Poland, where she was the group leader of the Laboratory of Mitochondrial Biogenesis. In 2014 she was awarded the title of full professor by the President of Republic of Poland. In 2017 Agnieszka Chacinska and her group has moved to the Centre of New Technologies, University of Warsaw. Agnieszka is interested in mechanisms and pathology of mitochondrial biology, especially biogenesis, transport and degradation of proteins as well as cellular responses to mitochondrial stress. She has published over 70 papers in these research areas.
Prof. Agnieszka Chacińska is a member of the eLIFE Board of Reviewing Editors in biochemistry and cell biology research fields.

Andrew Marshall, Chief Editor, Nature Biotechnology
Andrew Marshall is Chief Editor of Nature Biotechnology; he was appointed in 2000 when its impact factor was 11.4. He oversees all bioengineering research at the journal, coordinates the magazine and frequently speaks about biotechnology and translation at conferences, and also organizes meetings and symposia in this area. Previously, he was Editor of Current Opinion in Biotechnology. He has written hundreds of articles and editorials in the trade and popular media, including The Economist and Popular Science. He is a voluntary professor at the University of Miami. He graduated with a First with Honors and his postdoctoral work was carried out at King’s College London, where he received the Helen White Prize. In 2015, he was voted by Scientific American among the top 100 most influential people in biotech. Together with Atlas Ventures, Bay City Capital, Merck and J&J, he has pioneered networking events for faculty termed SciCafés in Boston, San Francisco, New York, San Diego, Houston, London and Singapore, which showcase rising stars in academia to early-stage investors and industry R&D leaders. He has consulted for Roche, Symphony Capital, Invitrogen, the Robertson Therapeutic Development Fund and Haystack Sciences.

Stefanie Boehm, Editor, EMBO
Stefanie Boehm studied Biochemistry at Goethe-University in Frankfurt and received her PhD from LMU Munich in 2011 where she worked on cell cycle regulation and the ubiquitin-proteasome system in S. cerevisiae with Alex Buchberger. As a postdoc in Kara Bernstein’s lab at the University of Pittsburgh she studied factors regulating genome stability, before joining the Department of Translational Genomics at the University of Cologne to analyze molecular determinants of lung cancer. Stefanie joined The EMBO Journal as an editor in 2019.

Eric Westhof, Editor, RNA
Eric Westhof graduated in biophysics at Liège University. He worked at Regensburg University and at the University of Wisconsin-Madison as a post-doctoral fellow. In 1981, he moved to the Institut de Biologie Moléculaire et Cellulaire du CNRS in Strasbourg and is now Emeritus Professor of Structural Biochemistry at the University of Strasbourg. His research activities are centered on the relationships between sequences, three-dimensional structures, evolution and functions of RNA molecules and their complexes. His editing activities focus on Nucleic Acids and he is editor of RNA, Nucleic Acids Research, Journal of Molecular Recognition and Biochemical and Biophysical Research Communications. He is a member of EMBO, Deutsche Akademie der Naturforscher LEOPOLDINA, Academia Europaea and the French Académie des Sciences.

Join us on Sat, June 15, starting at 11:30!
The RNA junior scientists are pleased to host the workshop on “Publishing and the Editorial process”, which will bring together Chief Editors, Senior Editors and Reviewing Editors to discuss the future of scientific publishing, currently considered a billion-dollar industry.
The workshop is structured as a panel discussion which will cover the following topics:

o Difference between open access and standard subscription-based publication
o Policies regarding open access (current EU laws versus US laws)
o Dilemma between unpublished pre-prints (BioRxiv) and peer-reviewed articles, including concerns regarding the possibility of refusing publication if a manuscript has been shared as unpublished pre-print.
o The review process in general:
• differences in the review process between the different journals
• what each journal requires for publishing
• transparency of the review process

The workshop will start with brief presentations from each Editor representing their Journal, followed by an open panel discussion.